Biotechnology Stocks
| # | Últimos 7 días | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4030 |  FBIO Fortress Biotech, Inc. - Common Stock | 2.09 USD | +2.45% | +0.48% | -19.62% | -25.62% | 69.70 M USD | ||
| 4032 |  TENX Tenax Therapeutics, Inc. - Common Stock | 1.86 USD | -2.62% | -5.10% | -9.71% | -75.36% | 69.61 M USD | ||
| 4037 |  CSBR Champions Oncology, Inc. - Common Stock | 4.98 USD | +2.05% | -1.19% | -4.05% | -24.20% | 69.31 M USD | ||
| 4040 |  ONCY Oncolytics Biotech Inc. - Common Stock | 0.54 USD | -10.00% | -16.92% | -31.65% | -57.48% | 68.86 M USD | ||
| 4044 |  HRTX Heron Therapeutics, Inc. - Common Stock | 0.36 USD | -5.26% | 0.00% | +9.09% | -72.52% | 68.35 M USD | ||
| 4050 |  XBIT XBiotech Inc. - Common Stock | 2.20 USD | +0.46% | 0.00% | +1.38% | -16.03% | 67.07 M USD | ||
| 4052 |  HYFT MindWalk Holdings Corp. - Common Stock | 1.43 USD | -4.67% | +3.62% | +6.72% | -30.24% | 66.80 M USD | ||
| 4054 |  RNTX Rein Therapeutics, Inc. - Common Stock | 0.77 USD | -2.53% | -7.23% | -12.50% | -30.00% | 66.43 M USD | ||
| 4055 |  SPRO Spero Therapeutics, Inc. - Common Stock | 1.14 USD | -2.56% | -9.52% | -3.39% | -52.10% | 66.39 M USD | ||
| 4063 |  NTHI NeOnc Technologies Holdings, Inc. - Common Stock | 2.53 USD | -6.64% | -17.32% | -36.75% | -71.15% | 65.62 M USD | ||
| 4074 |  PLRX Pliant Therapeutics, Inc. - Common Stock | 1.00 USD | +1.01% | -5.66% | -11.50% | -32.43% | 61.92 M USD | ||
| 4079 |  ELOX Eloxx Pharmaceuticals, Inc. | 15.18 USD | +2.02% | -4.65% | -5.01% | +51.80% | 61.27 M USD | ||
| 4081 |  MREO Mereo BioPharma Group plc - American Depositary Shares | 0.38 USD | +8.57% | 0.00% | +58.33% | -81.90% | 60.68 M USD | ||
| 4084 |  GOSS Gossamer Bio, Inc. - Common Stock | 9.88 USD | -2.95% | -11.71% | +6486.67% | +287.45% | 60.37 M USD | ||
| 4089 |  RNXT RenovoRx, Inc. - Common Stock | 1.33 USD | -2.92% | -15.29% | -32.49% | +18.75% | 60.02 M USD | ||
| 4091 |  KLRS Kalaris Therapeutics, Inc. - Common Stock | 2.51 USD | -1.95% | -10.68% | -31.42% | -75.46% | 59.75 M USD | ||
| 4097 |  IBIO iBio, Inc. - Common Stock | 0.92 USD | -8.91% | -17.86% | -29.23% | -60.00% | 59.16 M USD | ||
| 4103 |  BOLD Boundless Bio, Inc. - Common Stock | 2.58 USD | -2.27% | -1.53% | -9.79% | +122.41% | 58.69 M USD | ||
| 4112 |  ALDX Aldeyra Therapeutics, Inc. - Common Stock | 0.95 USD | -1.04% | -27.48% | -35.81% | -83.22% | 57.31 M USD | ||
| 4114 |  PDSB PDS Biotechnology Corporation - Common Stock | 1.02 USD | -4.67% | +43.66% | +251.72% | +2.00% | 57.09 M USD |
Noticias Biotechnology Stocks
El fármaco de Pharvaris para el angioedema hereditario muestra alivio más rápido
Raymond James inicia cobertura de Kymera Therapeutics con Mejor Rendimiento
Raymond James inicia cobertura de Nektar con calificación de rendimiento de mercado
Palisade Bio inicia cobertura con Mejor Rendimiento según Raymond James
Raymond James reitera su calificación de Liquidia en medio de presentaciones legales
Tenax Therapeutics pausa temporalmente la inscripción en el ensayo LEVEL-2 de TNX-103 para modificar los criterios; solicita reunión con la FDA
Ginkgo Bioworks apoyará a los X-Labs de la NSF con acceso a su laboratorio
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |